JPH0326967A - Analysis of nitrite ion and analytical element - Google Patents
Analysis of nitrite ion and analytical elementInfo
- Publication number
- JPH0326967A JPH0326967A JP16199289A JP16199289A JPH0326967A JP H0326967 A JPH0326967 A JP H0326967A JP 16199289 A JP16199289 A JP 16199289A JP 16199289 A JP16199289 A JP 16199289A JP H0326967 A JPH0326967 A JP H0326967A
- Authority
- JP
- Japan
- Prior art keywords
- nitrite ion
- analytical element
- layer
- analytical
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 title claims abstract description 21
- 229940005654 nitrite ion Drugs 0.000 title claims abstract description 20
- 238000004458 analytical method Methods 0.000 title claims description 23
- -1 amine compound Chemical class 0.000 claims abstract description 44
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 23
- 125000000664 diazo group Chemical group [N-]=[N+]=[*] 0.000 claims abstract description 14
- 150000001875 compounds Chemical class 0.000 claims abstract description 11
- 239000003792 electrolyte Substances 0.000 claims abstract description 10
- 150000004820 halides Chemical class 0.000 claims abstract description 9
- 238000004040 coloring Methods 0.000 claims description 11
- 239000002253 acid Substances 0.000 claims description 10
- 229910052736 halogen Inorganic materials 0.000 claims description 7
- 150000002367 halogens Chemical class 0.000 claims description 2
- 210000001124 body fluid Anatomy 0.000 abstract description 28
- 239000010839 body fluid Substances 0.000 abstract description 28
- 238000006243 chemical reaction Methods 0.000 abstract description 28
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 abstract description 22
- 239000011780 sodium chloride Substances 0.000 abstract description 11
- 230000035945 sensitivity Effects 0.000 abstract description 9
- 239000012954 diazonium Substances 0.000 abstract description 3
- 150000001989 diazonium salts Chemical class 0.000 abstract description 3
- IOVCWXUNBOPUCH-UHFFFAOYSA-N Nitrous acid Chemical compound ON=O IOVCWXUNBOPUCH-UHFFFAOYSA-N 0.000 abstract description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract description 2
- 239000007788 liquid Substances 0.000 abstract 1
- 239000010410 layer Substances 0.000 description 61
- 238000000576 coating method Methods 0.000 description 12
- 239000000243 solution Substances 0.000 description 12
- 239000011248 coating agent Substances 0.000 description 11
- 229920001577 copolymer Polymers 0.000 description 11
- 210000003296 saliva Anatomy 0.000 description 9
- 230000007480 spreading Effects 0.000 description 9
- 206010006326 Breath odour Diseases 0.000 description 8
- 238000001514 detection method Methods 0.000 description 8
- 238000005259 measurement Methods 0.000 description 8
- 238000000034 method Methods 0.000 description 8
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 8
- 238000011161 development Methods 0.000 description 7
- 239000000835 fiber Substances 0.000 description 7
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 5
- 239000008187 granular material Substances 0.000 description 5
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
- 108010010803 Gelatin Proteins 0.000 description 4
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 4
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 4
- 150000007513 acids Chemical class 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 229920000159 gelatin Polymers 0.000 description 4
- 239000008273 gelatin Substances 0.000 description 4
- 235000019322 gelatine Nutrition 0.000 description 4
- 235000011852 gelatine desserts Nutrition 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 229920002401 polyacrylamide Polymers 0.000 description 4
- 235000010288 sodium nitrite Nutrition 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 3
- QMMFVYPAHWMCMS-UHFFFAOYSA-N Dimethyl sulfide Chemical compound CSC QMMFVYPAHWMCMS-UHFFFAOYSA-N 0.000 description 3
- 239000004677 Nylon Substances 0.000 description 3
- 239000012790 adhesive layer Substances 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 229920001778 nylon Polymers 0.000 description 3
- 229920000139 polyethylene terephthalate Polymers 0.000 description 3
- 239000005020 polyethylene terephthalate Substances 0.000 description 3
- 239000011148 porous material Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- HVBSAKJJOYLTQU-UHFFFAOYSA-N 4-aminobenzenesulfonic acid Chemical compound NC1=CC=C(S(O)(=O)=O)C=C1 HVBSAKJJOYLTQU-UHFFFAOYSA-N 0.000 description 2
- 229920000936 Agarose Polymers 0.000 description 2
- 239000001856 Ethyl cellulose Substances 0.000 description 2
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 2
- 208000032139 Halitosis Diseases 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 239000004793 Polystyrene Substances 0.000 description 2
- 229920000297 Rayon Polymers 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 150000004982 aromatic amines Chemical class 0.000 description 2
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 235000010980 cellulose Nutrition 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 238000007334 copolymerization reaction Methods 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 235000019325 ethyl cellulose Nutrition 0.000 description 2
- 229920001249 ethyl cellulose Polymers 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- AMXOYNBUYSYVKV-UHFFFAOYSA-M lithium bromide Chemical compound [Li+].[Br-] AMXOYNBUYSYVKV-UHFFFAOYSA-M 0.000 description 2
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 2
- 235000019645 odor Nutrition 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 229920000191 poly(N-vinyl pyrrolidone) Polymers 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 229920002223 polystyrene Polymers 0.000 description 2
- IOLCXVTUBQKXJR-UHFFFAOYSA-M potassium bromide Chemical compound [K+].[Br-] IOLCXVTUBQKXJR-UHFFFAOYSA-M 0.000 description 2
- 239000001103 potassium chloride Substances 0.000 description 2
- 235000011164 potassium chloride Nutrition 0.000 description 2
- NROKBHXJSPEDAR-UHFFFAOYSA-M potassium fluoride Chemical compound [F-].[K+] NROKBHXJSPEDAR-UHFFFAOYSA-M 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- JHJLBTNAGRQEKS-UHFFFAOYSA-M sodium bromide Chemical compound [Na+].[Br-] JHJLBTNAGRQEKS-UHFFFAOYSA-M 0.000 description 2
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 239000004408 titanium dioxide Substances 0.000 description 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- DZSVIVLGBJKQAP-UHFFFAOYSA-N 1-(2-methyl-5-propan-2-ylcyclohex-2-en-1-yl)propan-1-one Chemical compound CCC(=O)C1CC(C(C)C)CC=C1C DZSVIVLGBJKQAP-UHFFFAOYSA-N 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 235000012766 Cannabis sativa ssp. sativa var. sativa Nutrition 0.000 description 1
- 235000012765 Cannabis sativa ssp. sativa var. spontanea Nutrition 0.000 description 1
- 229920000623 Cellulose acetate phthalate Polymers 0.000 description 1
- 229920001747 Cellulose diacetate Polymers 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical compound S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 239000005909 Kieselgur Substances 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 101100208473 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) lcm-2 gene Proteins 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 229920002845 Poly(methacrylic acid) Polymers 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- 229920002978 Vinylon Polymers 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 125000005396 acrylic acid ester group Chemical group 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 150000001491 aromatic compounds Chemical class 0.000 description 1
- 239000010425 asbestos Substances 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 description 1
- 229940092714 benzenesulfonic acid Drugs 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- UDSAIICHUKSCKT-UHFFFAOYSA-N bromophenol blue Chemical compound C1=C(Br)C(O)=C(Br)C=C1C1(C=2C=C(Br)C(O)=C(Br)C=2)C2=CC=CC=C2S(=O)(=O)O1 UDSAIICHUKSCKT-UHFFFAOYSA-N 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 229910001622 calcium bromide Inorganic materials 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- WGEFECGEFUFIQW-UHFFFAOYSA-L calcium dibromide Chemical compound [Ca+2].[Br-].[Br-] WGEFECGEFUFIQW-UHFFFAOYSA-L 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 235000009120 camo Nutrition 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 1
- 235000005607 chanvre indien Nutrition 0.000 description 1
- 238000007705 chemical test Methods 0.000 description 1
- 238000003618 dip coating Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 235000010944 ethyl methyl cellulose Nutrition 0.000 description 1
- 239000001761 ethyl methyl cellulose Substances 0.000 description 1
- 238000007765 extrusion coating Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 239000003365 glass fiber Substances 0.000 description 1
- 239000011487 hemp Substances 0.000 description 1
- 230000013632 homeostatic process Effects 0.000 description 1
- 150000003840 hydrochlorides Chemical class 0.000 description 1
- 229910000037 hydrogen sulfide Inorganic materials 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 239000011147 inorganic material Substances 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 238000010030 laminating Methods 0.000 description 1
- 229910000464 lead oxide Inorganic materials 0.000 description 1
- OTCKOJUMXQWKQG-UHFFFAOYSA-L magnesium bromide Chemical compound [Mg+2].[Br-].[Br-] OTCKOJUMXQWKQG-UHFFFAOYSA-L 0.000 description 1
- 229910001623 magnesium bromide Inorganic materials 0.000 description 1
- 229960002337 magnesium chloride Drugs 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 229940050906 magnesium chloride hexahydrate Drugs 0.000 description 1
- DHRRIBDTHFBPNG-UHFFFAOYSA-L magnesium dichloride hexahydrate Chemical compound O.O.O.O.O.O.[Mg+2].[Cl-].[Cl-] DHRRIBDTHFBPNG-UHFFFAOYSA-L 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- FQPSGWSUVKBHSU-UHFFFAOYSA-N methacrylamide Chemical compound CC(=C)C(N)=O FQPSGWSUVKBHSU-UHFFFAOYSA-N 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 239000002557 mineral fiber Substances 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- LNOPIUAQISRISI-UHFFFAOYSA-N n'-hydroxy-2-propan-2-ylsulfonylethanimidamide Chemical compound CC(C)S(=O)(=O)CC(N)=NO LNOPIUAQISRISI-UHFFFAOYSA-N 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- YEXPOXQUZXUXJW-UHFFFAOYSA-N oxolead Chemical compound [Pb]=O YEXPOXQUZXUXJW-UHFFFAOYSA-N 0.000 description 1
- 210000001819 pancreatic juice Anatomy 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 238000005375 photometry Methods 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920002006 poly(N-vinylimidazole) polymer Polymers 0.000 description 1
- 229920000172 poly(styrenesulfonic acid) Polymers 0.000 description 1
- 239000004584 polyacrylic acid Substances 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920005596 polymer binder Polymers 0.000 description 1
- 239000002491 polymer binding agent Substances 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 229920000098 polyolefin Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229940005642 polystyrene sulfonic acid Drugs 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 235000015277 pork Nutrition 0.000 description 1
- 229940094035 potassium bromide Drugs 0.000 description 1
- 229960002816 potassium chloride Drugs 0.000 description 1
- 239000011698 potassium fluoride Substances 0.000 description 1
- 235000003270 potassium fluoride Nutrition 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 239000002964 rayon Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229910052895 riebeckite Inorganic materials 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011775 sodium fluoride Substances 0.000 description 1
- 235000013024 sodium fluoride Nutrition 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 238000002798 spectrophotometry method Methods 0.000 description 1
- 229950000244 sulfanilic acid Drugs 0.000 description 1
- 150000003460 sulfonic acids Chemical class 0.000 description 1
- 150000003464 sulfur compounds Chemical class 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 229920003002 synthetic resin Polymers 0.000 description 1
- 239000000057 synthetic resin Substances 0.000 description 1
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 239000003021 water soluble solvent Substances 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
- 239000002492 water-soluble polymer binding agent Substances 0.000 description 1
- 210000002268 wool Anatomy 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
Abstract
Description
【発明の詳細な説明】
〔1業上の利用分野〕
本発明は各種体液戊分の臨床化学検査に用いられる体液
分析方法及び分析素子に関し、特に亜硝酸イオンの分析
1こ関する。DETAILED DESCRIPTION OF THE INVENTION [Field of Industrial Application] The present invention relates to a body fluid analysis method and an analysis element used in clinical chemical tests of various body fluids, and particularly relates to the analysis of nitrite ions.
臨床化学分析に供する試料としては、各種体液を用いる
ことが圧倒的に多い。中でも血液、特に血清は、通常恒
常性が維持されていること、全身の代謝動態、あるいは
各種臓器情報を得やすいこと、採取に比較的侵襲が少な
いことなど数多くの利点から一般的な試料として用いら
れている。尿も比較的よく用いられる検体であり、その
他胃液、膵液、腸液、胆汁、髄液も試料に供されること
がある。Various body fluids are overwhelmingly used as samples for clinical chemical analysis. Among them, blood, especially serum, is commonly used as a sample because of its many advantages, such as normally maintaining homeostasis, making it easy to obtain information on whole-body metabolic dynamics and various organs, and being relatively less invasive to collect. It is being Urine is a relatively commonly used specimen, and gastric juice, pancreatic juice, intestinal fluid, bile, and cerebrospinal fluid may also be used as samples.
また唾液については、その分泌生理について比較的よく
親察されているが、臨床医学領域では最近までまったく
無視されていた分析試料である。Saliva is an analysis sample that has been completely ignored until recently in the field of clinical medicine, although its secretory physiology is relatively well understood.
しかし患者に最も負担をかけず随時に採取しうる試料で
あり、特殊な場合を除けば量的にも十分得られ、特別な
前処理を必要とせず、臨床化学用試料として数多くの長
所を持っていて今後研究の発展に伴い利用の機会も多く
なることと考えられる.前記唾液成分の検出は、臨床化
学的な目的のみならず、社会的秩序の法的維持、緊急の
場における簡易迅速な判断或は家庭における衛生的で日
常的な簡便なチェックにまで拡り、各種の分析素子が数
多く(例えば特開昭60−178828号、同63−5
8257号等)提案、開示されており、口臭のチェック
にまで及んでいる。However, it is a sample that can be collected at any time with the least burden on the patient, can be obtained in sufficient quantity except in special cases, does not require special pretreatment, and has many advantages as a sample for clinical chemistry. It is thought that there will be more opportunities to use it in the future as research develops. Detection of saliva components is not only for clinical chemistry purposes, but also extends to the legal maintenance of social order, quick and simple judgments in emergency situations, and simple daily hygienic checks at home. There are many different types of analytical elements (for example, Japanese Patent Application Laid-open Nos. 60-178828 and 63-5).
No. 8257, etc.) have been proposed and disclosed, and even check for bad breath.
口臭中の主な臭気或分としては、揮発性硫黄化合物、ア
ルコール化合物、アルデヒド化合物、アミン化合物、ア
ンモニア等が証明されている。特に口腔より発生する臭
気或分については、硫化水素、メチルメルカブ.タン、
ジメチルサルファイド等のメルカブト化合物が主或分で
あることが知られている。よっだ口臭測定の目的で、呼
気又は唾液中のメルカブト化合物を検出する方法が特開
昭57−135360号、特開昭57− 148252
号、特開昭58−191957号及び特開昭60−17
8828号に提案されている。Volatile sulfur compounds, alcohol compounds, aldehyde compounds, amine compounds, ammonia, etc. have been proven to be the main odors in bad breath. In particular, some odors emitted from the oral cavity are caused by hydrogen sulfide, methylmerkab. Tan,
It is known that mercabuto compounds such as dimethyl sulfide are the main component. A method for detecting mercabuto compounds in exhaled breath or saliva for the purpose of measuring bad breath is disclosed in JP-A-57-135360 and JP-A-57-148252.
No., JP-A-58-191957 and JP-A-60-17
No. 8828.
しかしこれらの方法は、口臭を十分に検知するには測定
感度が低かったり、測定感度は十分であっても試薬の安
定性が悪い等の欠点を有しており、口臭を正確l:測定
することはできなかった。However, these methods have drawbacks such as the measurement sensitivity being too low to adequately detect bad breath, and the stability of the reagents being poor even if the measurement sensitivity is sufficient, making it difficult to accurately measure bad breath. I couldn't do that.
更に特開昭63−1口464号には、メルカブト化合物
を指標とする口臭検知では感度的に無理であるとして前
記口臭と相関を有する唾液中の亜硝酸イオン検量線を指
標として、亜硝酸イオンをジアゾ反応で発色させる試薬
及びそれを含浸させた試験紙及び分析素子による口臭検
知方法が提案されている。Furthermore, JP-A-63-1-464 states that it is impossible to detect halitosis using mercabuto compounds as an indicator due to its sensitivity, and that a nitrite ion calibration curve in saliva, which has a correlation with the above-mentioned halitosis, is used as an indicator to detect nitrite ions. A method for detecting bad breath using a reagent that develops color through a diazo reaction, a test paper impregnated with the reagent, and an analytical element has been proposed.
この方法は亜硝酸イオンとジアゾ反応する化合物とボリ
マー酸を含みジアゾ発色により呈色する試薬(以後単に
呈色試薬と称す)の反応の迅速・簡便性とその安定性に
基いて11戊されている。This method has been developed based on the rapidity and simplicity of the reaction and its stability between a compound that reacts with nitrite ions in diazo and a reagent containing a polymeric acid that develops color by diazo coloring (hereinafter simply referred to as color reagent). There is.
しかし、今までに提案された方法では、未だ感度的に不
充分である。However, the methods proposed so far are still insufficient in sensitivity.
本発明の目的は、体液試料中等に存在する亜硝酸イオン
を高感度に、かつ迅速、簡便、精度よく定1する分析方
法及び該分析に用いられる分析素子を提供することにあ
る。An object of the present invention is to provide an analytical method for determining nitrite ions present in body fluid samples with high sensitivity, quickly, simply, and with high precision, and an analytical element used in the analysis.
前記した本発明の目的は、亜硝酸イオンでジアゾ発色す
る化合物と、ハロゲンイオンを遊離することのない酸を
組或に含む亜硝酸イオン発色試薬に拠る亜硝酸イオン分
析系において、前記分析系に電解質ハロゲン化物を存在
させることを特徴とする亜硝酸イオン分析方法及び前記
亜硝酸イオン発色試薬に、更に電解質ハロゲン化物を含
有させた分析素子によって達戊される。The object of the present invention is to provide a nitrite ion analysis system based on a nitrite ion coloring reagent containing a compound that develops diazo color with nitrite ions and an acid that does not liberate halogen ions. This is achieved by a nitrite ion analysis method characterized by the presence of an electrolyte halide and an analytical element in which the nitrite ion coloring reagent further contains an electrolyte halide.
本発明に係る亜硝酸イオンでジアゾ発色する化合物はジ
アゾ成分、カップリング或分から構或される。The compound that develops diazo color with nitrite ion according to the present invention is composed of a diazo component and a coupling component.
ジアゾ戊分は、亜硝酸と反応してジアゾニウム塩を形成
する化合物であり、第一級アミノ基を有\
するアミン化合物である。好ましいアミン化合物として
は、複素環アミン、芳香族アミン誘導体があげられる。Diazo bokun is a compound that reacts with nitrous acid to form a diazonium salt, and is an amine compound with a primary amino group. Preferred amine compounds include heterocyclic amines and aromatic amine derivatives.
これらのアミン化合物は、無機塩例えば塩酸塩、硫酸塩
及び有機酸の状態で用いることが好ましい。These amine compounds are preferably used in the form of inorganic salts, such as hydrochlorides, sulfates, and organic acids.
カップリング成分は、ジアゾニウム塩と反応する化合物
であり、アミノ基及び/まt;は水酸基を有する芳香族
化合物、まt;はその誘導体である。The coupling component is a compound that reacts with the diazonium salt, and is an aromatic compound having an amino group and/or a hydroxyl group, and is a derivative thereof.
また力ソゾリング戊分が芳香族アミンの鴫含は、有機酸
塩、無機酸塩で用いてもよい。Furthermore, when the sosoling component is an aromatic amine, organic acid salts or inorganic acid salts may be used.
これら2つの戊分を水または水可溶性の溶媒に溶解また
は分散状態にしてジアゾ反応発色試薬とする。この場合
、2つの戊分の比率、発色試薬の濃度は、検出すべき亜
硝酸イオンの濃度範囲をカバーするよう適当に調整され
る。ジアゾ反応発色試薬の反応には酸が必要である。These two components are dissolved or dispersed in water or a water-soluble solvent to form a diazo reaction coloring reagent. In this case, the ratio of the two components and the concentration of the coloring reagent are appropriately adjusted to cover the concentration range of nitrite ions to be detected. An acid is required for the reaction of the diazo reaction coloring reagent.
本発明に係るハロゲンイオンを遊離することのない酸と
しては、ハロゲンを含有しないか、含有していてもハロ
ゲンイオンを解離しない酸であって、例えば硫酸、硝酸
、スルファミン酸、燐酸などの無機酸、例えば、酢酸、
クロル酸、トリクロル酢酸、プロビオン酸、琥珀酸、安
息香酸、サリチル酸などのカルポン酸、例えばp一トル
エンスルホン酸、ベンゼンスルホン酸などの有機スルホ
ン酸、及びポリマー酸が用いられる。Acids that do not liberate halogen ions according to the present invention include acids that do not contain halogen or do not dissociate halogen ions even if they contain, such as inorganic acids such as sulfuric acid, nitric acid, sulfamic acid, and phosphoric acid. , for example, acetic acid,
Carboxylic acids such as chloroacid, trichloroacetic acid, probionic acid, succinic acid, benzoic acid, salicylic acid, organic sulfonic acids such as p-toluenesulfonic acid, benzenesulfonic acid, and polymeric acids are used.
ボリマー酸としては、ポリアクリル酸、ポリメタクリル
酸、アクリル酸−アクリル酸ブチル共重合体’(50:
50),エチレンーマレイン酸モノプチル共重合体、ポ
リスチレンスルホン酸、アクリルアミドー2−メチルエ
タンスルホン酸−アクリル酸ブチルースチレン共重合体
(15:80: 5 )、ポリ−2−メタアクリ口イル
オキシエチルホス7エー1・、2アクリルアミドー2−
メチルプロパンスルホン酸一アクリル酸ブチル共重合体
. (50:50)等である。Polymer acids include polyacrylic acid, polymethacrylic acid, acrylic acid-butyl acrylate copolymer' (50:
50), ethylene-monobutyl maleate copolymer, polystyrene sulfonic acid, acrylamide-2-methylethanesulfonic acid-butyl-styrene acrylate copolymer (15:80:5), poly-2-methacryloxyethyl Phos 7A 1, 2 Acrylamide 2-
Methylpropanesulfonic acid monobutyl acrylate copolymer. (50:50) etc.
尚かっこ内の数字は重合比率を表す。Note that the numbers in parentheses represent the polymerization ratio.
前二者を所定量混合して前記した呈色試薬とする。尚酸
戊分は唾液を分析系に供給した際に分析系のpHが0.
1〜2になる程度に含有されていればよい。A predetermined amount of the former two is mixed to form the above-mentioned coloring reagent. When saliva is supplied to the analysis system, the pH of the analysis system is 0.
It is sufficient that the content is 1 to 2.
次に本発明に係る電解質ハロゲン化物の例としては、弗
化ナトリウム、塩化ナトリウム、臭化ナトリウム、弗化
カリウム、塩化カリウム、臭化カリウム、塩化マグネシ
ウム、臭化マグネシウム、塩化カルシウム、臭化カルシ
ウム、塩化リチウム、臭化リチウム等が挙げられる。Examples of the electrolyte halides according to the present invention include sodium fluoride, sodium chloride, sodium bromide, potassium fluoride, potassium chloride, potassium bromide, magnesium chloride, magnesium bromide, calcium chloride, calcium bromide, Examples include lithium chloride and lithium bromide.
電解質ハロゲン化物は、分析系において塩化ナトリウム
換算でジアゾ発色試薬1vLに対し0.1〜20wL存
在させられる。The electrolyte halide is present in an amount of 0.1 to 20 wL in terms of sodium chloride per 1 vL of the diazo coloring reagent in the analysis system.
本発明の亜硝酸イオン分析素子の形態として、好ましく
は、液不透性で透明な支持体上に前記試薬類を含む少な
くとも1つの反応層及び多孔性展開層を有する一体型多
層分析素子(特公昭53−21677号、特開昭55−
164359号、同55−90859号、同57−19
7466号、同57−101760号、同57−101
761号、同58−90167号等)が挙げられる。The nitrite ion analysis element of the present invention is preferably in the form of an integrated multilayer analysis element (specially Publication No. 53-21677, JP-A-55-
No. 164359, No. 55-90859, No. 57-19
No. 7466, No. 57-101760, No. 57-101
No. 761, No. 58-90167, etc.).
上記反応層は水溶性ボリマー又は親水性かつ有機溶媒可
溶性のボリマーをバインダとして支持体上に塗布するこ
とによって層として設けることができる。水溶性ポリマ
ーバインダとしてはゼラチン、7タル化ゼラチン等のゼ
ラチン誘導体、ヒドロキンエチルセルロース、カルポキ
シメチルセルロースナトリウム塩等の水溶性セルロース
誘導体、ポリビニルアルコール、ポリ (N−ビニルピ
ロリドン)、ポリアクリルアミド、ポリメタクリルアミ
ド、アクリルアミドとアクリル酸エステルの共重合体、
ポリ (モノ又はジアルキル置換)アクリルアミド、ポ
リ (モノ又はジアルキル置換)メタクリルアミド及び
これらの水溶性共重合体等か挙げられ、好ましくはゼラ
チン、ポリアクリルアミド及びアクリルアミドとアクリ
ル酸エステルρ共重合体が用いられる。親水性かつ有機
溶媒可溶性ポリマーバインダとしては、ポリ (N−ビ
ニルピロリドン)、ポリ (N−ビニルイミダゾール)
、ポリ (N−ビニルトリアゾール)及びこれらの誘導
体又はそれらの共重合体、エチルセルロース、メチルセ
ルロース等のセルロース誘導体等が挙げられる。The reaction layer can be provided as a layer by applying a water-soluble polymer or a hydrophilic and organic solvent-soluble polymer as a binder onto the support. Examples of water-soluble polymer binders include gelatin, gelatin derivatives such as pentatalated gelatin, water-soluble cellulose derivatives such as hydroquine ethyl cellulose and carboxymethyl cellulose sodium salt, polyvinyl alcohol, poly(N-vinylpyrrolidone), polyacrylamide, and polymethacrylamide. , a copolymer of acrylamide and acrylic ester,
Examples include poly (mono- or dialkyl-substituted) acrylamide, poly (mono- or dialkyl-substituted) methacrylamide, and water-soluble copolymers thereof, and preferably gelatin, polyacrylamide, and acrylamide and acrylic acid ester ρ copolymers are used. . Hydrophilic and organic solvent-soluble polymer binders include poly(N-vinylpyrrolidone) and poly(N-vinylimidazole).
, poly(N-vinyltriazole), derivatives thereof or copolymers thereof, cellulose derivatives such as ethyl cellulose and methyl cellulose, and the like.
また、反応層に含ませる試薬類が2種以上にわたる場合
、この試薬類を同一反応層内に一緒に混合して含有させ
ても、また、2種以上の試薬類を2つ又はそれ以上の別
々の反応層に別々に或は組合せて含有させてもよい。In addition, when two or more types of reagents are contained in a reaction layer, even if these reagents are mixed together in the same reaction layer, two or more types of reagents may be mixed together in the same reaction layer. They may be contained separately or in combination in separate reaction layers.
上記反応層の膜厚は所望に応じて任意に選択することが
可能であるが、好ましくは1〜200μm1更に好まし
くは5〜100μmである。The thickness of the reaction layer can be arbitrarily selected as desired, but is preferably 1 to 200 μm, and more preferably 5 to 100 μm.
前記の液不透性の透明支持体(以下、支持体と略す)は
、液不透性で、かつ透明であればその種類を問わないが
、例えば酢酸セルロース、ポリエチレンテレフタレ−1
・、ボリカーポ不一ト又はボリスチレンのような種々の
重合体材料のみならず、ガラスのごとき無機材料も用い
ることが可能である。該支持体の厚さは任意であるが、
好ましくは5〜250μmである。The liquid-impermeable transparent support (hereinafter abbreviated as support) may be of any type as long as it is liquid-impermeable and transparent, but examples include cellulose acetate and polyethylene terephthalate.
- It is possible to use various polymeric materials such as polycarbonate or polystyrene, but also inorganic materials such as glasses. The thickness of the support is arbitrary, but
Preferably it is 5 to 250 μm.
更に反応層を積層する支持体の内側面に、場合によって
は透明な下塗り層を使用して反応層ど支持体との接着性
を改良することができる。Furthermore, a transparent undercoat layer may be used on the inner surface of the support on which the reaction layer is laminated, as the case may be, to improve the adhesion between the reaction layer and the support.
本発明に係る多孔性展開層には体液試料を均一迅速に延
展するために体液試料と自由に接触し得る相互連絡空隙
孔(短径5μm〜300μmが好ましい)を有する多孔
性構造が存在していることが必要である。The porous spreading layer according to the present invention has a porous structure having interconnecting pores (preferably a short diameter of 5 μm to 300 μm) that can freely contact the body fluid sample in order to uniformly and quickly spread the body fluid sample. It is necessary to be present.
好ましい例としてはサイズlO〜350μmの粒状体、
或は40〜400メッシュの繊維から1つ以上選ばれた
素材により構成される構造体が挙げられる。Preferable examples include granules having a size of 10 to 350 μm;
Another example is a structure made of one or more materials selected from 40 to 400 mesh fibers.
該粒状体の材料としては、珪藻土、二酸化チタン、硫酸
バリウム、酸化亜鉛、酸化鉛、微結晶セルロース、珪砂
、ガラス、シリカゲル、架橋デキストラン、架橋ポリア
クリルアミド、アガロース、架橋アガロース、各種合成
樹脂(ポリスチレンなと)などが挙げられる。Materials for the granules include diatomaceous earth, titanium dioxide, barium sulfate, zinc oxide, lead oxide, microcrystalline cellulose, silica sand, glass, silica gel, cross-linked dextran, cross-linked polyacrylamide, agarose, cross-linked agarose, and various synthetic resins (such as polystyrene). ), etc.
また、本発明に係る多孔性展開層に用いる繊維としては
、バルブ、粉末濾紙、綿、麻、絹、羊毛、キチン、キト
サン、セルロースエステル、ビスコースレーヨン、綱ア
ンモニアレーヨン、ボリアミド(6−ナイロン, 66
−ナイロン、610−ナイロンなど)、ポリエステル(
ポリエチレンテレフタレートなど)、ポリオレフィン(
ポリプロピレン、ビニロンなど)、ガラス繊維、石綿な
どの植物性、動物性、鉱物性の繊維、合或一,半合戊−
.再生一繊維を用いることができ、あるいはこれらを混
合して用いても良い。Further, the fibers used in the porous spreading layer according to the present invention include bulb, powder filter paper, cotton, hemp, silk, wool, chitin, chitosan, cellulose ester, viscose rayon, ammonia rayon, polyamide (6-nylon, 66
-nylon, 610-nylon, etc.), polyester (
polyethylene terephthalate, etc.), polyolefins (
polypropylene, vinylon, etc.), glass fiber, asbestos, and other vegetable, animal, and mineral fibers;
.. A single recycled fiber may be used, or a mixture of these may be used.
このような粒状体、繊維、あるいは粒状体と繊雄の混合
物を塗布及び/又は製膜することにより、体液試料と自
由に接触し得る相互連絡空隙孔を有する多孔性構造が存
在する多孔性展開贋を形戊する。これらの粒状体、繊維
等は前記したバインダを用いて粒子同志が点接着する形
で製膜され、例えば特開昭49−53888号、同55
−90859号、同57−67860号の方法を適用す
ることができる。By coating and/or forming a film with such granules, fibers, or a mixture of granules and fibers, a porous structure in which a porous structure with interconnecting pores that can freely contact the body fluid sample is created. Form a fake. These granules, fibers, etc. are formed into a film using the above-mentioned binder in such a way that the particles adhere to each other at points.
The methods of No. 90859 and No. 57-67860 can be applied.
前記多孔性展開層は、(1)一定容量の体液試料を単位
面積当り反応層に均一に配布する機能を有するものであ
る。その上、更に、特公昭53−21677号に記載さ
れた性能、すなわち (2)体液試料中の反応を阻害す
る物質又は要因を除去する機能及び/又は(3)分光光
度分析を行うときに支持体を経て透過する測定光を反射
するバックグランド作用を行う機能を有するものであれ
ば好ましい。The porous spreading layer has the function of (1) uniformly distributing a certain volume of body fluid sample to the reaction layer per unit area; Furthermore, the performance described in Japanese Patent Publication No. 53-21677, i.e. (2) the ability to remove substances or factors that inhibit reactions in body fluid samples, and/or (3) support when performing spectrophotometric analysis. It is preferable that it has the function of performing a background effect of reflecting measurement light transmitted through the body.
例えば、特公昭53−21677号に記載された二酸化
チタン及び二酢酸セルロースから或るブラッシュボリマ
と呼称される非繊維多孔質媒体の展開層、特開昭57−
94658号、同57−12847号、同57−197
466号及び同58−70161号等に記載された繊維
構造展開層、特開昭58−90167号に記載された粒
子結合体構造展開層が挙げられる。For example, a spread layer of a non-fibrous porous medium called brush volima made of titanium dioxide and cellulose diacetate is described in Japanese Patent Publication No. 53-21677;
No. 94658, No. 57-12847, No. 57-197
Examples include the fiber structure spreading layer described in Japanese Patent Application Laid-open No. 466 and No. 58-70161, and the particle combination structure spreading layer described in JP-A-58-90167.
本発明の分析素子における展開層の膜厚は、その空隙率
によって決定されるべきであるが、好ましくは約lOO
〜600μ慣、更に好ましくは約150〜400/11
11である。また、空隙率は好ましくは約20〜85%
である。The thickness of the spreading layer in the analytical element of the present invention should be determined by its porosity, but is preferably about lOO
~600μ, more preferably about 150-400/11
It is 11. In addition, the porosity is preferably about 20 to 85%.
It is.
また該展開層には他の付加的な添加剤として、例えば保
恒剤等、種々の添加剤も所望に応じて添加することもで
きる。Further, various other additives such as preservatives and the like may be added to the developing layer as desired.
lnJ記の一体型多贋分析素子は必要に応じて、例えば
特願昭63−207282号記載の接着層、米国特許3
,992. 158号記載の反射層、下塗り層、米国特
許4,042,335号記載の放射線プロッキング層、
米国特許4.066,403号記載のバリャ層、米国特
許4,166,093号記載のマイグレーション阻止層
、特開昭55−90859号記載のスカベンジャ層等を
任意に組合せて本発明の目的に合せた任意の構戊とする
ことがでさる。The integrated type multi-counterfeit analysis element described in lnJ may be prepared by using, for example, the adhesive layer described in Japanese Patent Application No. 63-207282, or the adhesive layer described in U.S. Pat.
,992. 158, a subbing layer, a radiation blocking layer as described in U.S. Pat. No. 4,042,335,
The barrier layer described in U.S. Pat. No. 4,066,403, the migration prevention layer described in U.S. Pat. No. 4,166,093, the scavenger layer described in JP-A-55-90859, etc. can be arbitrarily combined to meet the objectives of the present invention. Any structure can be used.
これら分析素子の種々の層は、本発明に係る支持体上I
こ所望のW4fRに従い、従来写真工業において用いら
れているスライドホッパ塗布法、押出し塗布法、浸漬塗
布法等を適宜選択して用い、順次積層することで任意の
厚みの層を塗設することができる。The various layers of these analytical elements are arranged on the support according to the invention.
In accordance with the desired W4fR, it is possible to apply a layer of any thickness by sequentially laminating layers using the slide hopper coating method, extrusion coating method, dip coating method, etc. that have been conventionally used in the photographic industry. can.
次に本発明の分析素子及びその使用についてその態様例
を用いて説明する。Next, the analytical element of the present invention and its use will be explained using an example of its embodiment.
第1図において、lは臨床化学用分析装置本体、第2図
において2は分析素子である。分析素子2は観測窓21
aを有するマウントベース2lと、体液点着孔22aを
有するマウント力バー22との間に一定の試薬を含浸し
た反応層に展開層を積層した倹出子(フィルム)23を
介装してなり、該マウント力バー22の表面には試薬デ
ータを判別するための基準発色コード24が5ビットで
判別できるように設置されている。該分析素子2は前記
本体lの前面に設けた素子挿入口itより挿入すること
により本体I内に設置した一対の素子搬入用のローラに
よって挟持され、インキュベーション手段の中に搬入さ
れる。インキュベーション手段は分析素子2を設定温度
に保持すると共に、体液試料を点着した分析素子2を設
定時間後に測光部に移送するようにしたものである。In FIG. 1, 1 is the main body of the clinical chemistry analyzer, and in FIG. 2, 2 is the analytical element. Analysis element 2 is observation window 21
A film 23 in which a developing layer is laminated on a reaction layer impregnated with a certain reagent is interposed between a mount base 2l having a body fluid spotting hole 22a and a mount force bar 22 having a body fluid spotting hole 22a. A reference coloring code 24 for identifying reagent data is installed on the surface of the mounting force bar 22 so that it can be identified in 5 bits. The analytical element 2 is inserted through the element insertion opening IT provided on the front surface of the main body I, is held between a pair of rollers for carrying the element installed in the main body I, and is carried into the incubation means. The incubation means maintains the analytical element 2 at a set temperature and transfers the analytical element 2 on which the body fluid sample has been deposited to the photometry section after a set time.
次に簡便に体液(例えば唾液)を採取し特別な分析機器
を必要とせず分析を行う分析素子の態様例を第3図に示
す。Next, FIG. 3 shows an embodiment of an analytical element that easily collects body fluid (for example, saliva) and analyzes it without requiring special analytical equipment.
上記例は透明な支持体上に反応層を設け、その上に各種
体液戊分の夫々に不活性で体液を均一に延展しうる多孔
性の展開層を設けた形態である。In the above example, a reaction layer is provided on a transparent support, and a porous spreading layer is provided on top of the reaction layer, which is inert to each of the various body fluids and can uniformly spread the body fluids.
体液(例えば唾液)採取部材(採取部材と略称)は体液
の所定量の採取が可能で且つ採取された体液を含蓄し更
に少なくとも反応層、展開層からなる検示部材に容易に
必要体液量を放出供与できる柔軟な多孔質の素材が選ば
れる。A body fluid (e.g., saliva) collection member (abbreviated as collection member) is capable of collecting a predetermined amount of body fluid, contains the collected body fluid, and can easily supply the required amount of body fluid to a detection member consisting of at least a reaction layer and a development layer. A flexible porous material is chosen that can provide release.
前記検示部材と採取部材は連結されており、検示部材の
展開層に採取部材が接面するようにそれらのホールダ間
を可撓性または折曲げ自在とした連結部材で連結し前記
両部材面を離接自在としている。The detection member and the collection member are connected, and the holders are connected by a flexible or bendable connection member so that the collection member is in contact with the developed layer of the detection member. The surfaces can be freely moved in and out.
更に分析素子の性能補完或は保全、測定操作の利便のた
め各種の補助部材、補助構或層を付帯させることができ
る。例えば分析素子未使用時のカバー 検示及び採取部
材圧接維持のためのホック、両部材を保持するマウント
等を備えることが好ましい。Furthermore, various auxiliary members, auxiliary structures, or layers can be added to supplement or maintain the performance of the analytical element and to facilitate measurement operations. For example, it is preferable to include a hook for detecting the cover when the analytical element is not in use and for maintaining pressure on the sampling member, a mount for holding both members, and the like.
第3図に於て、1は検示部材であって、支持体11上に
試薬を含有する反応層l2、更にその上に展開層13を
積層した構戊をもち、体液点着孔口41,観測窓42を
有するマウント4に挟着されている。In FIG. 3, reference numeral 1 denotes a detection member, which has a structure in which a reaction layer 12 containing a reagent is laminated on a support 11, and a development layer 13 is further laminated thereon. , and is clamped to a mount 4 having an observation window 42.
2は採取部材であって、検示部材1と採取部材2を連結
する連結部材3に接着123によって接着されており、
体液点着口4lを蔽って展開層l3に対面している。Reference numeral 2 denotes a collection member, which is bonded to a connecting member 3 that connects the detection member 1 and the collection member 2 with an adhesive 123;
It covers the body fluid spot 4l and faces the development layer l3.
連結部材3は展開層l3に対して開閉自在にその一端が
マウント4に固定され、他端に設けたホツク3lによっ
てマウント4に嵌着されている。尚該連結部材は分析素
子未使用時閉じて検示部材1及び採取部材2のカバーと
なり、開いて体液を採取する時の“猟み゛′となり、再
び閉じてホソク3lを嵌着すれば採取部材2と展開層1
3の間の圧接を維持することができる。The connecting member 3 is fixed to the mount 4 at one end so as to be openable and closable with respect to the developing layer l3, and is fitted onto the mount 4 by a hook 3l provided at the other end. The connecting member closes when the analysis element is not in use and serves as a cover for the detection member 1 and collection member 2, opens to serve as a "hunting point" when collecting body fluids, and closes again to fit the hose 3l to collect the body fluid. Member 2 and development layer 1
A pressure contact between 3 and 3 can be maintained.
又、用いる体液試料の量は、体液試料が十分含浸される
量以上であれば任意であるが、lcm2当たり好ましく
は5〜50μQであり、更に好ましくは約5〜20μQ
である。通常約lOμQの体液試料を適用することが好
ましい。The amount of the body fluid sample to be used is arbitrary as long as it is sufficient to be impregnated with the body fluid sample, but it is preferably 5 to 50 μQ per lcm2, and more preferably about 5 to 20 μQ.
It is. It is usually preferred to apply a sample of body fluid of about 10μQ.
以下に実施例を挙げて本発明を更に具体的に説明するが
、これによって本発明の実施態様が限定されるものでは
ない。The present invention will be explained in more detail with reference to Examples below, but the embodiments of the present invention are not limited thereto.
実施例−1
(1) 分析素子の作製
透明な厚さ約180μmの下引き済ポリエチレンテレフ
タレート支持体上に、下記の塗布液を塗布、乾燥して反
応層とした。乾燥後の膜厚は、約2 0 11 rrr
であった。Example 1 (1) Preparation of analytical element The following coating solution was coated on a transparent subbed polyethylene terephthalate support having a thickness of about 180 μm and dried to form a reaction layer. The film thickness after drying is approximately 2 0 11 rrr
Met.
(反応層)
N−1−ナフチル−N′一エチル
エチレンジアミン蓚酸塩 3.0gスル
ファニル酸 1.3g2−アク
リルアミドー2−メチル
プロパンスルホン酸−アクリル酸ブチル共重合体(共重
合比率50 : 50) 7.7gト リ
ト ン■X − 100
2.9g(ローム&ハース社製
)
ポリアクリルアミド 8.5g蒸留
水を加えて200.0gとした。(Reaction layer) N-1-naphthyl-N'-ethylethylenediamine oxalate 3.0 g sulfanilic acid 1.3 g 2-acrylamide 2-methylpropanesulfonic acid-butyl acrylate copolymer (copolymerization ratio 50:50) 7 .7g bird
Tons X - 100
2.9 g (manufactured by Rohm & Haas) Polyacrylamide 8.5 g Distilled water was added to make 200.0 g.
下記組成の塗布液を塗布、乾燥して多孔性展開層を積層
した。乾燥後の膜厚は、約280μmでありIこ 。A coating solution having the following composition was applied and dried to laminate a porous development layer. The film thickness after drying is approximately 280 μm.
(展開層)
濾紙粉末D(アドバンテンク東洋社製) 24.0gト
リ ト ン X − 100
2.4 κ(ロ
ーム&ハース社製)
スチレンーグリシジルメタアクリレート共重合体(t合
比9:l) 7.4gホIJ(N−ビニ
ノレピロリドン) 1.3gキシレン
40.0gブタ,−ル
20.Ogこのようにして作威
した多層フイルムを1 .5cmXl.5cmに断裁し
、プラスチックマウントIこ封入して比較用の分析素子
一(1)とした。(Development layer) Filter paper powder D (manufactured by Advanten Toyo Co., Ltd.) 24.0g Triton X-100
2.4 κ (manufactured by Rohm & Haas) Styrene-glycidyl methacrylate copolymer (t ratio 9:l) 7.4 g HoIJ (N-vininolepyrrolidone) 1.3 g xylene
40.0g pork
20. 1. The multilayer film produced in this way. 5cmXl. It was cut into 5 cm pieces and sealed in a plastic mount to prepare analytical element 1 (1) for comparison.
更に、上記反応層塗布液に塩化ナトリウム1.00gを
加えた以外は、上記と同様にして、本発明の分析素子−
lを作戊した。Furthermore, an analytical element of the present invention was prepared in the same manner as above except that 1.00 g of sodium chloride was added to the reaction layer coating solution.
I created l.
又、上記展開層塗布液に塩化ナl− IJウム2.40
gを加えた以外は、上記と同様にして、本発明の分析素
子−2を作成した。In addition, 2.40% of sodium chloride was added to the developing layer coating solution.
Analytical element-2 of the present invention was prepared in the same manner as above except that g was added.
更に、上記反応層塗布液に塩化ナトリウム1.00gを
加え、上記展開層塗布液に塩化ナトリウム2.40gを
加えた以外は、上記と同様にして、本発明の分析素子−
3を作成した。Furthermore, an analytical element of the present invention was prepared in the same manner as above except that 1.00 g of sodium chloride was added to the reaction layer coating solution and 2.40 g of sodium chloride was added to the development layer coating solution.
3 was created.
(2)分析素子による亜硝酸イオンの測定10μg/m
f2, 40ug/mQ及び80μg/mQの濃度の亜
硝酸ナ]・リウム水溶液を調製し、上記分析素子(1)
及び1〜3の展開層上に、上記の亜硝酸ナトリウム水溶
液を1011(2点着した。点着30# fi、546
niの干渉フィルタを用いて反射濃度(Dr)を測定し
た。(2) Measurement of nitrite ion using analytical element 10μg/m
f2, prepare a sodium/lium nitrite aqueous solution with a concentration of 40 ug/mQ and 80 ug/mQ, and add the above analytical element (1).
And on the developing layers 1 to 3, the above sodium nitrite aqueous solution 1011 (2 spots was applied. 30# fi, 546
Reflection density (Dr) was measured using a ni interference filter.
その結果を表一lに示す。The results are shown in Table I.
表− 1
上表から明らかなように、本発明の分析素子は、比較の
分析素子に比べて、高い反射濃度を示し、特に塩化ナl
・リウムを展開層に加えた本発明の分析素子2及び3で
、著しく高い反射濃度を示すことが明らかであり、本発
明の分析素子により亜硝酸イオンを高感度に測定できる
ことが明らかである。Table 1 As is clear from the above table, the analytical element of the present invention exhibits a higher reflection density than the comparative analytical element, especially for sodium chloride.
- It is clear that Analytical Elements 2 and 3 of the present invention, in which lium is added to the developing layer, exhibit significantly high reflection concentrations, and it is clear that nitrite ions can be measured with high sensitivity using the analytical element of the present invention.
実施例−2
(1) 分析素子の作戊
透明な厚さ180μmの下引き済ポリエチレンテレ7タ
レート支持体上に、実施例−1に記載の組成の反応層塗
布液を塗布した。乾燥後の反応層の膜厚は、21μmで
あった。Example 2 (1) Preparation of analytical element A reaction layer coating solution having the composition described in Example 1 was coated on a transparent subbed polyethylene tere-7 tallate support having a thickness of 180 μm. The thickness of the reaction layer after drying was 21 μm.
次に、この上層に、N・ビニルビロリドンー酢酸ビニル
共重合体(共重合比率80 : 20)の5%ブタノー
ル溶液(0.1mMのブロムフェノールブルー含有)を
塗布・乾燥して接着層(乾燥膜厚3μm)とした。Next, on this upper layer, a 5% butanol solution (containing 0.1mM bromophenol blue) of N.vinylpyrrolidone-vinyl acetate copolymer (copolymerization ratio 80:20) was applied and dried to form an adhesive layer ( The dry film thickness was 3 μm).
更に、実施例−1に記載の組或の展開層塗布液を塗布、
乾燥(乾燥膜厚260μ+n) L、比較用の分析素子
−(2)を作或した。Furthermore, applying a certain spreading layer coating solution as described in Example-1,
Drying (dry film thickness 260μ+n) L, analytical element-(2) for comparison was prepared.
又、塩化ナトリウム( 1.75g) ,塩化カリウム
(2.24g)、塩化マグネシウム・6水塩(3.05
g)、塩化力ルンウム(1.66g)及び硫酸ナトリウ
ム(4.26g)、をそれぞれ添加した上記展開層塗布
液を作り、上記と同様に塗布、乾燥して、本発明の分析
素子4 ,5 ,6 .7及び比較用の分析素子−(3
)を作或し lこ 。Also, sodium chloride (1.75g), potassium chloride (2.24g), magnesium chloride hexahydrate (3.05g)
g), chloride (1.66 g) and sodium sulfate (4.26 g) were respectively added to the above-mentioned developing layer coating solution, which was coated and dried in the same manner as above to form analytical elements 4 and 5 of the present invention. ,6. 7 and analytical element for comparison (3
).
(2) 分析素子による亜硝酸イオンの測定実施例−1
の(2)と同様の方法で、10.40及び80μg/m
I2の濃度の亜硝酸ナトリウム水溶液を用いて反射濃度
を測定した。その結果を表−2に示す。(2) Example of measurement of nitrite ion using analytical element-1
In the same manner as (2), 10.40 and 80 μg/m
Reflection density was measured using an aqueous sodium nitrite solution with a concentration of I2. The results are shown in Table-2.
表−2から明らかなように、本発明の分析素子は、比較
の分析素子に比べて、著しく高感度に亜硝酸イオンを検
出することができる。As is clear from Table 2, the analytical element of the present invention can detect nitrite ions with significantly higher sensitivity than the comparative analytical element.
実施例−3
(1)分析素子の作成
実施例−lで作或した展開層に塩化ナトリウムを含有さ
せた本発明の分析素子−2と同様にして、展開層怠布液
に添加する塩化ナトリウムの量を1.20g. 4.8
0g. 9.60gとして、それぞれ添加し、本発明の
分析素子8.9.10を作戊した。Example 3 (1) Preparation of analytical element In the same manner as the analytical element 2 of the present invention in which sodium chloride was added to the developing layer prepared in Example 1, sodium chloride was added to the developing layer coating solution. The amount of 1.20g. 4.8
0g. 9.60 g of each was added to prepare analytical elements 8.9.10 of the present invention.
(2)分析素子による亜硝酸イオンの測定自然な状態で
採取した唾液に、亜硝酸ナトリウムを加え、10, 4
0. 80μg/mQの濃度の亜硝酸ナトリウム含有混
合唾液を調整し、上記分析素子の展開層上にその10μ
Qをそれぞれ点着した。(2) Measurement of nitrite ions using an analytical element Sodium nitrite was added to saliva collected under natural conditions, and 10,4
0. Prepare a mixed saliva containing sodium nitrite with a concentration of 80 μg/mQ, and place 10 μg of it on the spreading layer of the analytical element.
I scored each Q.
点着l分後に、546nmの干渉フィルタを用いて反射
濃度(D『)を測定した。After 1 minute of spotting, the reflection density (D') was measured using a 546 nm interference filter.
表−3
表−3から明らかなように、本発明の分析素子により、
著しく高感度に亜硝酸イオンを測定することができる。Table 3 As is clear from Table 3, the analytical element of the present invention allows
Nitrite ions can be measured with extremely high sensitivity.
本発明によって高感度な亜硝酸イオンの分析方法及び分
析素子構戊がえられた。The present invention provides a highly sensitive method for analyzing nitrite ions and a structure of an analytical element.
【図面の簡単な説明】
第1図は本発明に係る臨床化学用分析装置である。
第2図は本発明の分析素子の1態様例の分解説明図、第
3図は体液検査に用いる簡易測定用分析素子の断面図で
ある。
第2図に於て;
21・・・マウントベース、
22・・・マウント力バー
23・・・検出子(フィルム)、
第3図に於て;
1・・・検示部材、
2・・・体液採取部材、
3・・・連結部材、
4・・・マウント、
1l・・・支持体、
l2・・・反応層、
l3・・・展開層。BRIEF DESCRIPTION OF THE DRAWINGS FIG. 1 shows a clinical chemistry analyzer according to the present invention. FIG. 2 is an exploded explanatory view of one embodiment of the analytical element of the present invention, and FIG. 3 is a sectional view of the analytical element for simple measurement used for body fluid testing. In Fig. 2; 21...Mount base, 22...Mount force bar 23...Detector (film), In Fig. 3; 1...Detection member, 2... Body fluid collection member, 3... Connecting member, 4... Mount, 1l... Support, l2... Reaction layer, l3... Deployment layer.
Claims (2)
ンイオンを遊離することのない酸を組成に含む亜硝酸イ
オン発色試薬に拠る亜硝酸イオン分析系において、前記
分析系に電解質ハロゲン化物を存在させることを特徴と
する亜硝酸イオン分析方法。(1) In a nitrite ion analysis system based on a nitrite ion coloring reagent containing a compound that develops diazo color with nitrite ions and an acid that does not liberate halogen ions, an electrolyte halide is present in the analysis system. A nitrite ion analysis method characterized by:
ンイオンを遊離することのない酸を組成に含む亜硝酸イ
オン発色試薬に拠る亜硝酸イオン分析系を構成する分析
素子に電解質ハロゲン物を含有させたことを特徴とする
亜硝酸イオン分析素子。(2) An electrolyte halogen is contained in the analytical element constituting a nitrite ion analysis system based on a nitrite ion coloring reagent containing a compound that develops diazo color with nitrite ions and an acid that does not release halogen ions. A nitrite ion analysis element characterized by:
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP16199289A JPH0326967A (en) | 1989-06-23 | 1989-06-23 | Analysis of nitrite ion and analytical element |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP16199289A JPH0326967A (en) | 1989-06-23 | 1989-06-23 | Analysis of nitrite ion and analytical element |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH0326967A true JPH0326967A (en) | 1991-02-05 |
Family
ID=15745978
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP16199289A Pending JPH0326967A (en) | 1989-06-23 | 1989-06-23 | Analysis of nitrite ion and analytical element |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH0326967A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2012185147A (en) * | 2011-02-18 | 2012-09-27 | Miura Co Ltd | Quantitative method of nitrite ion |
-
1989
- 1989-06-23 JP JP16199289A patent/JPH0326967A/en active Pending
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2012185147A (en) * | 2011-02-18 | 2012-09-27 | Miura Co Ltd | Quantitative method of nitrite ion |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4132528A (en) | Analytical element for the analysis of liquids under high pH conditions | |
JPS6371652A (en) | Multilayer test supporter for analyzing and measuring component of liquid sample | |
US20150369830A1 (en) | Articles and methods for rapid thc detection | |
CA2497245A1 (en) | Test element with a one layer reaction film | |
CA1312266C (en) | Analytical method and element for protein assay | |
JPH0726960B2 (en) | Dry whole blood analysis element | |
JP2003533678A (en) | Assay device with timer function | |
JPH0668494B2 (en) | Integrated multilayer analytical element for albumin analysis | |
EP0114403B1 (en) | Multilayer analytical element | |
JPH029310B2 (en) | ||
JPS59171864A (en) | Multi-layered analytical element for quantitative analysis of bilirubin | |
JPS60263858A (en) | Analysis element and use thereof for complete-blood hemoglobin assay | |
JPH0326967A (en) | Analysis of nitrite ion and analytical element | |
JP4990692B2 (en) | Immunochromatographic assay and kit | |
JPS62116258A (en) | Preparation of liquid analytical element | |
US4435362A (en) | Integral multilayer analytical element for the assay of total protein | |
JPH0522519B2 (en) | ||
JPH04501319A (en) | A chemical sensor for calcium ions using a porous polymer thin film and a method for detecting calcium ions using the same | |
JP3799395B2 (en) | Hematocrit value measuring method and test tool | |
JPH01289495A (en) | Alcohol analyzing element | |
JPS58179359A (en) | Multilayer analyzing material for quantitative determination of protein | |
JPH02108945A (en) | Analysis element for high-viscosity sample | |
JPH02290541A (en) | Analysis element | |
JPS63261164A (en) | Dry type analysis element for analyzing albumin | |
JPH0654311B2 (en) | Analytical element for measuring bad breath with nitrite ion |